U.S. SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 10-Q
Mark One
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended May 31, 2025
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to _______
COMMISSION FILE NO. 333-228161
EvoAir Holdings
Inc.
(Exact name of registrant as specified in its charter)
Nevada
98-1353613
8713
(State or Other Jurisdiction of
IRS Employer
Primary Standard Industrial
Incorporation or Organization)
Identification Number
Classification Code Number
EvoAir Holdings Inc.
31-A2, Jalan 5/32A
6 ½ Miles , Off Jalan Kepong
52000 Kuala Lumpur, Malaysia
Tel. +603 6243 3379
(Address and telephone number of registrant’s
executive office)
Copies to:
Lawrence Venick, Esq.
Loeb & Loeb LLP
2206-19 Jardine House
1 Connaught Place, Central
Hong Kong SAR
Tel: +852.3923.1111
Fax: +852.3923.1100
Indicate by checkmark whether the issuer: (1)
has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
☒ No ☐
Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit and post such files). Yes ☒
No ☐
Indicate by check mark whether the registrant
is a large accelerated filed, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☒
Smaller reporting company ☒
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by checkmark whether the registrant is
a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
No ☒
Applicable
Only to Issuer Involved in Bankruptcy Proceedings During the Preceding Five Years:
Indicate by checkmark whether the issuer has filed
all documents and reports required to be filed by Section 12, 13 and 15(d) of the Securities Exchange Act of 1934 after the distribution
of securities under a plan confirmed by a court. Yes ☐ No ☐
Applicable
Only to Corporate ISSUERS:
Indicate the number of shares outstanding of each
of the issuer’s classes of common stock, as of the most practicable date:
Class
Outstanding as of July 11, 2025
Common Stock, $ 0.001
27,180,631
EvoAir Holdings Inc.
Part I
FINANCIAL INFORMATION
Item 1
FINANCIAL STATEMENTS
3
Item 2
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
20
Item 3
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
30
Item 4
CONTROLS AND PROCEDURES
30
PART II
OTHER INFORMATION
Item 1
LEGAL PROCEEDINGS
31
Item 2
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
31
Item 3
DEFAULTS UPON SENIOR SECURITIES
31
Item 4
MINE SAFETY DISCLOSURES
31
Item 5
OTHER INFORMATION
31
Item 6
EXHIBITS
32
SIGNATURES
33
2 | Page
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
EVOAIR
HOLDINGS INC.
UNAUDITED
CONDENSED CONSOLIDATED BALANCE SHEETS
(In
U.S. Dollars, except share data or otherwise stated)
AS
OF MAY 31, 2025 AND AUGUST 31, 2024
May 31, 2025
August 31, 2024
(Unaudited)
(Audited)
ASSETS
Current assets
Cash and cash equivalents
$ 81,016
$ 152,985
Accounts receivable
59,495
62,914
Inventories
435,021
460,047
Deposit, prepayments and other receivables
82,182
114,806
Total current assets
657,714
790,752
Non-current assets
Property, plant and equipment, net
278,951
357,778
Operating lease right-of-use assets
138,640
199,647
Deferred offering cost
3,210,094
449,576
Technology-related intangible assets, net
48,774,101
51,481,358
Total non-current assets
52,401,786
52,488,359
TOTAL ASSETS
$ 53,059,500
$ 53,279,111
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable and accruals
$ 282,062
$ 267,900
Other payables
164,411
95,831
Deferred revenue
16,014
10,012
Hire purchase creditor
7,075
8,758
Amounts due to shareholders
2,174,737
1,202,692
Operating lease liability - current
97,619
99,445
Total current liabilities
2,741,918
1,684,638
Non-current liabilities
Hire purchase creditor
-
4,320
Operating lease liabilities
46,870
108,891
Total non-current liabilities
46,870
113,211
TOTAL LIABILITIES
2,788,788
1,797,849
Commitments and contingencies (Note 14)
-
-
Shareholders’ equity
Common stock, 250,000,000 authorized;
$ 0.001 par value, 27,180,631
and 25,685,591 shares issued and outstanding
as at May 31, 2025 and August 31, 2024 *
27,181
25,686
Additional paid in capital
97,492,063
91,513,818
Accumulated other comprehensive loss
( 129,114 )
( 48,827 )
Accumulated deficit
( 46,280,904 )
( 39,401,857 )
Non-controlling interest
( 838,514 )
( 607,558 )
Total shareholders’ equity
50,270,712
51,481,262
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
$ 53,059,500
$ 53,279,111
*
Retroactively restated to reflect 1-for-4 share consolidation effective on September 11, 2024.
The
accompanying footnotes are an integral part of these condensed consolidated financial statements.
3 | Page
EVOAIR
HOLDINGS INC.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In
U.S. Dollars, except share data or otherwise stated)
FOR
THE THREE AND NINE MONTHS ENDED MAY 31, 2025 AND 2024
Three months ended
Nine months ended
May 31, 2025
May 31, 2024
May 31, 2025
May 31, 2024
Revenue
$ 37,306
$ 89,616
$ 160,359
$ 222,108
Cost of revenue
8,505
56,741
168,681
244,142
Gross profit/(loss)
28,801
32,875
( 8,322 )
( 22,034 )
Operating expenses:
Selling and marketing expenses
5,566
23,646
20,264
61,849
General and administrative expenses
1,231,898
984,048
7,096,421
3,936,596
Total operating expenses
1,237,464
1,007,694
7,116,685
3,998,445
Loss from operation
( 1,208,663 )
( 974,819 )
( 7,125,007 )
( 4,020,479 )
Other income
Interest (expense)/income
( 32 )
( 32 )
147
44
Other income
21,857
410
24,130
90,915
Total other income
21,825
378
24,277
90,959
Loss from operation before income taxes
( 1,186,838 )
( 974,441 )
( 7,100,730 )
( 3,929,520 )
Income tax expenses
-
-
-
-
Net loss
$ ( 1,186,838 )
$ ( 974,441 )
$ ( 7,100,730 )
$ ( 3,929,520 )
Less: Net loss attributable to non-controlling interests
( 69,014 )
( 81,747 )
( 221,683 )
( 225,599 )
Net loss attributable to equity holders of the Company
( 1,117,824 )
( 892,694 )
( 6,879,047 )
( 3,703,921 )
Other comprehensive loss:
Foreign currency translation adjustment
( 103,798 )
( 86,717 )
( 89,560 )
( 170,798 )
Total comprehensive loss
( 1,221,622 )
( 979,411 )
( 6,968,607 )
( 3,874,719 )
Less: net comprehensive (loss)/income attributable to non-controlling interests
( 21,508 )
7,368
( 9,273 )
2,202
Net comprehensive loss attributable to equity holders of the Company
( 1,200,114 )
( 986,779 )
( 6,959,334 )
( 3,876,921 )
Net loss attributable to equity holders of the Company per common share:
Basic and diluted*
( 0.04 )
( 0.03 )
( 0.26 )
( 0.14 )
Weighted average number of common shares outstanding:
Basic and diluted*
27,180,631
25,685,591
26,709,695
25,676,029
*
Retroactively
restated to reflect 1-for-4 share consolidation effective on September 11, 2024
The
accompanying footnotes are an integral part of these condensed consolidated financial statements.
4 | Page
EVOAIR
HOLDINGS INC.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (DEFICIT)
(In
U.S. Dollars, except share data or otherwise stated)
FOR
THE THREE AND NINE MONTHS ENDED MAY 31, 2025 AND 2024
Common Stock
Additional
Accumulated other
Shares*
Amount
Paid in capital
Accumulated deficit
comprehensive loss
Shares to be issued
Non-controlling
interests
Total
Balance as of August 31, 2023
25,577,734
$ 25,578
$ 90,447,874
$ ( 13,523,266 )
$ ( 17,036 )
$ 1,066,052
$ ( 148,180 )
$ 77,851,022
Issuance of common stock for Cash
93,455
94
934,504
-
-
( 934,598 )
-
-
Issuance of common stock for service
14,402
14
131,440
-
-
( 131,454 )
-
-
Foreign currency translation adjustment
-
-
-
-
( 85,208 )
-
( 2,793 )
( 88,001 )
Net loss
-
-
-
( 1,444,323 )
-
-
( 79,998 )
( 1,524,321 )
Balance as of November 30, 2023
25,685,591
$ 25,686
$ 91,513,818
$ ( 14,967,589 )
$ ( 102,244 )
$ -
$ ( 230,971 )
$ 76,238,700
Foreign currency translation adjustment
-
-
-
-
6,293
-
( 2,373 )
3,920
Net loss
-
-
-
( 1,366,904 )
-
-
( 63,854 )
( 1,430,758 )
Balance as of February 29, 2024
25,685,591
$ 25,686
$ 91,513,818
$ ( 16,334,493 )
$ ( 95,951 )
$ -
$ ( 297,198 )
$ 74,811,862
Capital contribution
-
-
65,598
-
-
-
-
65,598
Foreign currency translation adjustment
-
-
-
-
( 94,085 )
-
7,368
( 86,717 )
Net loss
-
-
-
( 892,694 )
-
-
( 81,747 )
( 974,441 )
Balance as of May 31, 2024
25,685,591
$ 25,686
$ 91,579,416
$ ( 17,227,187 )
$ ( 190,036 )
$ -
$ ( 371,577 )
$ 73,816,302
Common Stock
Additional
Accumulated other
Shares
Shares*
Amount
Paid in capital
Accumulated deficit
comprehensive loss
to
be
issued
Non-controlling
interests
Total
Balance as of August 31, 2024
25,685,591
$ 25,686
$ 91,513,818
$ ( 39,401,857 )
$ ( 48,827 )
$ -
$ ( 607,558 )
$ 51,481,262
Issuance of common stock for consulting service
1,494,935
1,495
5,978,245
-
-
-
-
5,979,740
Fraction shares issued due to reverse stock split
105
-
-
-
-
-
-
-
Foreign currency translation adjustment
-
-
-
-
7,837
-
10,933
18,770
Net loss
-
-
-
( 4,555,401 )
-
-
( 85,503 )
( 4,640,904 )
Balance as of November 30, 2024
27,180,631
$ 27,181
$ 97,492,063
$ ( 43,957,258 )
$ ( 40,990 )
$ -
$ ( 682,128 )
$ 52,838,868
Foreign currency translation adjustment
-
-
-
-
( 5,834 )
-
1,302
( 4,532 )
Net loss
-
-
-
( 1,205,822 )
-
-
( 67,166 )
( 1,272,988 )
Balance as of February 28, 2025
27,180,631
$ 27,181
$ 97,492,063
$ ( 45,163,080 )
$ ( 46,824 )
$ -
$ ( 747,992 )
$ 51,561,348
Balance
27,180,631
$ 27,181
$ 97,492,063
$ ( 45,163,080 )
$ ( 46,824 )
$ -
$ ( 747,992 )
$ 51,561,348
Foreign currency translation adjustment
-
-
-
-
( 82,290 )
-
( 21,508 )
( 103,798 )
Net loss
-
-
-
( 1,117,824 )
-
-
( 69,014 )
( 1,186,838 )
Balance as of May 31, 2025
27,180,631
$ 27,181
$ 97,492,063
$ ( 46,280,904 )
$ ( 129,114 )
$ -
$ ( 838,514 )
$ 50,270,712
Balance
27,180,631
$ 27,181
$ 97,492,063
$ ( 46,280,904 )
$ ( 129,114 )
$ -
$ ( 838,514 )
$ 50,270,712
*
Retroactively
restated to reflect 1-for-4 share consolidation effective on September 11, 2024
The accompanying footnotes are an integral
part of these condensed consolidated financial statements.
5 | Page
EVOAIR
HOLDINGS INC.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In
U.S. Dollars, except share data or otherwise stated)
FOR
THE NINE MONTHS ENDED MAY 31, 2025 AND 2024
May 31, 2025
May 31, 2024
Cash flows from operating activities
Net loss
$ ( 7,100,730 )
( 3,929,520 )
Adjustments for non-cash income and expenses:
Depreciation
84,729
187,729
Amortization
2,707,257
3,118,041
Stock based expense
3,261,676
-
Changes in operating assets and liabilities:
Accounts receivables
3,419
( 12,647 )
Inventories
25,026
( 104,992 )
Deposit, prepayments and advances to suppliers
32,624
147,654
Operating lease right-of-use assets
61,007
61,351
Accounts payable and accruals
14,162
56,584
Deferred revenue
6,002
( 48,632 )
Operating lease liabilities
( 63,847 )
( 64,369 )
Other payables
68,580
( 6,258 )
Net cash used in operations
$ ( 900,095 )
$ ( 595,059 )
Cash flows from investing activity
Purchase of property, plant and equipment
( 5,902 )
( 102,414 )
Cash used in investing activity
$ ( 5,902 )
$ ( 102,414 )
Cash flows from financing activities
Loan from shareholders
972,045
524,587
Payments of hire purchase
( 6,003 )
( 5,885 )
Payment of deferred offering costs
( 42,454 )
( 449,576 )
Proceeds from capital contribution
-
65,598
Net cash generated from financing activities
$ 923,588
$ 134,724
Net increase/(decrease) in cash and cash equivalents
17,591
( 562,749 )
Effect of exchange rate changes
( 89,560 )
( 170,798 )
Cash and cash equivalents at start of period
152,985
779,049
Cash and cash equivalents at end of period
81,016
45,502
Supplemental disclosure of non-cash investing and financing
information :
Common stock issued for consulting service in related to Initial public offering
$ 2,718,064
$ -
The
accompanying footnotes are an integral part of these condensed consolidated financial statements.
6 | Page
EVOAIR
HOLDINGS INC.
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE THREE AND NINE MONTHS ENDED MAY 31, 2025, AND 2024
NOTE
1 – ORGANIZATION AND BUSINESS OPERATIONS
EvoAir
Holdings Inc. (formerly Unex Holdings Inc.) (the “Company”, “EVOH”, “we”, “us”, or “our”)
is a corporation established under the corporation laws in the State of Nevada, United States of America (“U.S”) on February
17, 2017. The Company has adopted an August 31 fiscal year end.
On
December 20, 2021, the Company and Low Wai Koon (“Dr. Low”) entered into a share transfer agreement, (the “EvoAir International
Share Transfer Agreement”), pursuant to which Dr. Low agreed to sell all of his ordinary shares of EvoAir International Limited
(“EvoAir International”) to the Company for a consideration of US$ 100 (“EvoAir Transaction”). EvoAir International,
through its subsidiaries upon completion of the Transactions (defined hereunder), is engaged in the research and development (“R&D”),
manufacturing, trading, sale of heating, ventilation and air conditioning (“HVAC”) products and related services in Asia.
Pursuant
to the terms of a share transfer agreement dated December 20, 2021, Dr. Low, the then sole executive officer and director of the Company
and the owner of 2,000,000 restricted shares of common stock, with par value of $ 0.001 per share (“Common Stock”) of the
Company (“EvoAir Shares”) representing approximately 67.34 % of the Company’s then issued and outstanding shares, sold
his entire shareholding of the Company to WKL Global Limited (“WKL Global”) for an aggregate consideration of $ 100 (“Change
of Control Transaction”). Upon completion of the Change of Control Transaction, WKL Global owned 2,000,000 shares, or approximately
67.34 % of the then issued and outstanding ordinary shares of the Company, which resulted in a change of control of the Company.
On
December 20, 2021, several transactions took place (together, the “Allotment Transactions”) whereby the Company issued and
allotted in aggregate 98,809,323 ordinary shares of common stock to certain parties. On completion of the Allotment Transactions, the
total number of issued and outstanding shares of common stock of the Company were 101,779,323 (“Then
Enlarged Share Capital”):
(A)
On
December 20, 2021, Dr. Low and Chan Kok Wei entered into a share exchange agreement with WKL Eco Earth Holdings Pte Ltd (“WKL
Eco Earth Holdings”), pursuant to which Dr. Low and Chan Kok Wei agreed to sell all their ordinary shares of WKL Green Energy
Sdn Bhd (“WKL Green Energy”) to WKL Eco Earth Holdings in consideration for the allotment and issuance to WKL Global
and Allegro Investment (BVI) Limited (“Allegro Investment”), a company incorporated in the British Virgin Islands (“BVI”)
with 50 % shareholdings held by Chan Kok Wei and Ong Bee Chen, respectively, of 24,000 shares and 6,000 EvoAir Shares, respectively,
or approximately 0.02 % and 0.01 % of the Then Enlarged Share Capital, respectively.
7 | Page
(B)
On
December 20, 2021, Dr. Low, Chan Kok Wei, Ong Bee Chen and certain sellers (“WKLEE Sellers”) entered into a share exchange
agreement with WKL Eco Earth Holdings, pursuant to which Dr. Low, Chan Kok Wei, Ong Bee Chen and WKLEE Sellers agreed to sell all
their ordinary shares of WKL Eco Earth Sdn Bhd (“WKL Eco Earth”) to WKL Eco Earth Holdings in consideration for the allotment
and issuance to WKL Global, Allegro Investment and WKLEE Sellers of 49,320 EvoAir Shares, 8,280 EvoAir Shares and in aggregate 14,400
shares, respectively, or approximately 0.05 %, 0.009 % and in aggregate 0.014 %, respectively, of the Then Enlarged Share Capital.
(C)
On
December 20, 2021, Tan Soon Hock, Ivan Oh Joon Wern and certain relevant interest holders (“Relevant Interest Holders”)
entered into an investment exchange agreement with WKL Eco Earth Holdings, pursuant to which Tan Soon Hock, Ivan Oh Joon Wern and
the Relevant Interest Holders agreed to sell all relevant interests in the EVOH and its subsidiaries (“EvoAir Group”
or the “Group”) to WKL Eco Earth Holdings in consideration for the allotment and issuance of 7,037,762 EvoAir Shares,
2,520,000 EvoAir Shares and in aggregate 6,001,794 EvoAir shares, respectively, or approximately 6.91 %, 2.48 % and in aggregate 5.90 %,
respectively, of the Then Enlarged Share Capital. The board of directors and majority shareholders of the Company have approved the
transaction.
(D)
On
December 20, 2021, Dr. Low entered into two deeds of assignment of intellectual properties with WKL Eco Earth Holdings, in respect
of Dr. Low’s patents and patent applications relating to eco-friendly air-conditioner condenser (external unit), evoair TM
and the trademarks and trademark applications described in the deeds of assignment thereunder, and in respect of Dr. Low’s
patents and patents applications relating to the portable air-conditioner, e-Cond EVO TM and the trademarks and trademark
applications as described in the deeds of assignment thereunder (together, the “IP Assignments”). Pursuant to the IP
Assignments, WKL Global, Allegro Investment and certain nominees shall be allotted and issued 63,362,756 EvoAir Shares, 14,297,259
EvoAir Shares and in aggregate 5,487,752 EvoAir Shares, respectively or approximately 62.25 %, 14.05 % and in aggregate 5.39 %, respectively
of the Then Enlarged Share Capital in consideration for the IP Assignments.
EvoAir
Transaction, Change of Control Transaction and Allotment Transactions are collectively to be referred to as the “Transactions”.
The closing of the Transactions (“Closing”) occurred on December 20, 2021 (the “Closing Date”).
From
and after the Closing Date, at which time EvoAir International transferred its HVAC business to the Company, the Company’s primary
operations will consist of the prior operations of EvoAir International and its subsidiaries.
EvoAir
International is a company incorporated in BVI on November 17, 2021. Effective from the December 20, 2021, it wholly owns WKL Eco Earth
Holdings, a company incorporated in Singapore on July 12, 2018, which in turn wholly owns (a) WKL Eco Earth, a Malaysian company incorporated
on May 17, 2017, and (b) WKL Green Energy, a Malaysian company incorporated on October 24, 2017. WKL Eco Earth Holdings acquired (c)
EvoAir Manufacturing (M) Sdn Bhd (“EvoAir Manufacturing”) on April 19, 2021, a Malaysian company incorporated on March 22,
2019, as well as acquiring (d) WKL EcoEarth Indochina Co Ltd (“WKL EcoEarth Indochina”), a Cambodia company incorporated
on February 4, 2021, (e) WKL Guanzhe Green Technology Guangzhou Co Ltd (“WKL Guanzhe”), a Chinese company incorporated on
April 6, 2021. EvoAir Manufacturing wholly owns (f) Evo Air Marketing (M) Sdn Bhd (“Evo Air Marketing”), a Malaysian company
incorporated on February 2, 2021.
On
June 15, 2022, the Company filed a Certificate of Amendment (the “Amendment”) to the Articles of Incorporation with Nevada’s
Secretary of State to change the name of the Company from Unex Holdings Inc. to EvoAir Holdings Inc. (the “Name Change”),
and the Name Change became market effective on November 4, 2022. Effective on November 11, 2022, the Company’s shares began trading
under the new ticker symbol “EVOH”.
On
November 21, 2023, the Company issued in aggregate, 52,107 shares of Common Stock to 15 referral agents (“Referral Agents”)
in consideration for their referral to the Company of certain investors. Each Referral Agent is a “non-U.S. Persons” as defined
in Regulation S.
8 | Page
On
November 21, 2023, the Company issued, in aggregate, 5,500 shares of Common Stock to two individuals in consideration for marketing services
provided to the Company by Artisan Creative Studio, a marketing entity based in Malaysia. Each of the individuals is a “non-U.S.
Persons” as defined in Regulation S.
Round
2 Stockholders
The
Company entered into a series of offerings for an aggregate of up to 6,000,000 shares of Common Stock at a per share purchase price of
$ 2.50 , as follows:
●
On
February 15, 2022, the Company entered into certain share subscription agreement with Ms. Ang Lee Kim Jane, who is a “non-U.S.
Persons” as defined in Regulation S of the Securities Act of 1933, as amended (the “Securities Act”) pursuant to
which the Company agreed to issue and sell 74,074 shares of Common Stock, at a per share purchase price of $ 2.50 , as part of a series
of offerings by the Company for an aggregate of up to 6,000,000 shares of Common Stock at a per share purchase price of $ 2.50 . The
gross proceeds were $ 185,185 .
●
On
June 3, 2022, the Company entered into certain share subscription agreement with Mr. Wong Hon Wai who is a “non-U.S. Persons”
as defined in Regulation S of the Securities Act pursuant to which the Company agreed to issue and sell 5,000 shares of Common Stock,
at a per share purchase price of $ 2.50 , as part of a series of offerings by the Company for an aggregate of up to 6,000,000 shares
of Common Stock at a per share purchase price of $ 2.50 . The gross proceeds were $ 12,500 .
●
On
October 25, 2022, the Company entered into Regulation S share subscription agreements with eight investors, each of whom represented
that it was a “non-U.S. Persons” as defined in Securities Act. On the same date, the Company entered into Regulation
D share subscription agreements with two investors, each of whom represented that it was an “Accredited Investors” as
defined in Regulation D of the Securities Act. Pursuant to the share subscription agreements, the Company agreed to issue and sell
in aggregate, (i) 129,621 shares of Common Stock to the Regulation S investors, and (ii) 15,000 shares of Common Stock to the Regulation
D investors, respectively, at a per share purchase price of $ 2.50 , as part of a series of offerings by the Company for an aggregate
of up to 6,000,000 shares of Common Stock at a per share purchase price of $ 2.50 . The gross proceeds in aggregate were $ 361,553 .
●
On
February 20, 2023, the Company entered into Regulation S share subscription agreements with eleven investors, each of whom represented
that it was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the share subscription
agreements, the Company agreed to issue and sell in aggregate, (i) 57,783 shares of Common Stock to the Regulation S investors, at
a per share purchase price of $ 2.50 as part of a series of the offerings by the Company for an aggregate of up to 6,000,000 shares
of Common Stock at a per share purchase price of $ 2.50 . The gross proceeds in aggregate were $ 144,443 .
●
On
July 13, 2023, the Company entered into Regulation S share subscription agreements with 31 investors, each of whom represented that
it was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the share subscription agreements,
the Company agreed to issue and sell in aggregate, (i) 250,132 shares of Common Stock to the Regulation S Investors, at a per share
purchase price of $ 2.50 as part of a series of the offerings by the Company for an aggregate of up to 6,000,000 shares of Common
Stock at a per share purchase price of $ 2.50 . The gross proceeds in aggregate were approximately $ 625,330 .
●
On
September 7, 2023, the Company entered into Regulation S share subscription agreements with 71 investors, each of whom represented
that it was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the share subscription
agreements, the Company agreed to issue and sell in aggregate, 365,164 shares of Common Stock to the Regulation S investors, at a
per share purchase price of $ 2.50 as part of a series of the offerings by the Company for an aggregate of up to 6,000,000 shares
of Common Stock at a per share purchase price of $ 2.50 . The gross proceeds in aggregate were approximately $ 912,889 .
●
On
November 21, 2023, the Company entered into a Regulation S share subscription agreement with Wong Chun Shoong who represented that
he was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the share subscription agreement,
the Company agreed to issue and sell in aggregate, 8,658 shares of Common Stock to the Regulation S investors, at a per share purchase
price of $ 2.50 as part of a series of the offerings by the Company for an aggregate of up to 6,000,000 shares of Common Stock at
a per share purchase price of $ 2.50 . The gross proceeds in aggregate were approximately $ 21,645 .
9 | Page
Reverse
Stock Split
On
April 12, 2024, the Company’s board of directors (the “Board”) unanimously resolved to effect a reverse stock split
of the Company’s common stock, par value $ 0.001 per share (the “Common Stock”), at a ratio of 1-for-4. Following such
resolution, on September 9, 2024, the Company filed a Certificate of Amendment (the “Certificate of Amendment”) with the
Secretary of State of the State of Nevada to effect the reverse stock split, with an effective time of 9:00AM. Eastern Time on September
11, 2024 (the “Reverse Stock Split”).
Split
Adjustment; Treatment of Fractional Shares
As
a result of the 1:4 Reverse Stock Split , each 4 pre-split shares of Common Stock outstanding will automatically combine into one new
share of Common Stock without any action on the part of the holders, and the number of outstanding shares of Common Stock was reduced
from 102,742,362 shares to 25,685,591 shares (subject to rounding up of fractional shares to the nearest whole number).
No
fractional shares were issued in connection with the Reverse Stock Split. Fractional shares were rounded up to the nearest whole number
Share
Issuance
On
November 25, 2024, the Company issued, in aggregate, 679,516 shares of Common Stock, representing 2.5 % of the issued and outstanding
shares of Common Stock to certain project management consultant in consideration for their services in relation to proposed initial public
offering.
On
November 25, 2024, the Company issued, in aggregate, 815,419 shares of Common Stock, representing 3.0 % of the issued and outstanding
shares of Common Stock to certain corporate and business consultant in consideration for their consulting services.
Details
of the Company’s subsidiaries:
SUMMARY
OF CONSOLIDATED SUBSIDIARIES
Subsidiaries
of EVOH
Attributable
interest
EvoAir
International Limited (British Virgin Islands)
100 %
Subsidiary
of EvoAir International Limited
WKL
Eco Earth Holdings Pte Ltd (Singapore)
100 %
Subsidiaries
of WKL Eco Earth Holdings Pte Ltd
WKL
Eco Earth Sdn Bhd (Malaysia)
100 %
WKL
Green Energy Sdn Bhd (Malaysia)
100 %
EvoAir
Manufacturing (M) Sdn Bhd (Malaysia)
67.5 %
WKL
EcoEarth Indochina Co Ltd (Cambodia)
55 %
WKL
Guanzhe Green Technology Guangzhou Co Ltd (China)*
62.5 %
Subsidiary
of EvoAir Manufacturing (M) Sdn Bhd
Evo
Air Marketing (M) Sdn Bhd (Malaysia)
100 %
*
Shareholding
of WKL Guanzhe Green Technology Guangzhou Co Ltd (China) has increased from 55 % to 62.5 % on August 14, 2024.
NOTE
2 – CHANGE OF CONTROL
Pursuant
to the terms of a share transfer agreement dated December 20, 2021, Dr. Low, the then sole executive officer and director of the Company
and the owner of 2,000,000 restricted shares of the Company’s ordinary shares representing approximately 67.34 % of the Company’s
then issued and outstanding shares, sold his entire shareholding of the Company to WKL Global for an aggregate consideration of $ 100 .
Upon completion of the Change of Control Transaction, WKL Global then owned 2,000,000 shares, or approximately 67.34 % of the Company’s
then issued and outstanding shares, which resulted in a change of control of the Company.
10 | Page
NOTE
3 – GOING CONCERN
The
Company’s financial statements as of May 31, 2025, is prepared using generally accepted accounting principles in the United States
of America (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities
in the normal course of business. The Company has not yet established a sustainable ongoing source of revenue sufficient to cover its
operating costs and allow it to continue as a going concern.
As
of May 31, 2025, the Company had an accumulated
deficit of $ 46,280,904 and
a working capital deficiency of $ 2,084,204 . As of August
31, 2024, the accumulated deficit was $ 39,401,857 and the working capital deficiency was $ 893,886 .
The Company incurred net loss of $ 7,100,730 and
$ 3,929,520 for
the nine months ended May 31, 2025, and 2024, respectively. The cash used in operating activities was $ 900,095 for
the nine months ended May 31, 2025, and the cash used in operating activities was $ 595,059 for
the nine months ended May 31, 2024, respectively. It was brought to the attention of the Management to assess going concern
considering all facts and circumstances about the foreseeable future of the Company as well as its assets and liabilities on the
basis that it will be able to realize and discharge them in the normal course of business.
To
address these challenges and ensure the Company’s long-term viability, Management has developed a strategic plan focused on the
continued development and expansion of its HVAC business. Key initiatives include:
●
Expansion
of Product Offerings: Broadening the range of HVAC products to meet diverse market needs.
●
Geographical
Expansion: Penetrating new markets to drive revenue growth.
●
Revenue
Diversification: Expanding customer segments across retail, commercial, industrial, and project-based clients, as well as private
label and licensing opportunities.
●
Improved
Profitability: Achieving economies of scale through operational efficiencies and growth.
Additionally,
the Company is actively pursuing plans to raise additional funding to support operations and business expansion. This includes preparations
to uplist on the Nasdaq Capital Market, which is expected to enhance access to capital and further strengthen the Company’s financial
position.
The
consolidated financials have been prepared assuming that the Company will continue as a going concern and accordingly financial statements
do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities
that might be necessary should the Company be unable to continue as a going concern.
NOTE
4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation and Principles of Consolidation:
The
accompanying consolidated financial statements have been prepared by the Company in accordance with U.S. GAAP for financial information
and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”).
The
consolidated financial statements include the accounts of EvoAir International, WKL Eco Earth Holdings, WKL Eco Earth, WKL Green Energy,
and its 67.5 % owned EvoAir Manufacturing which included a 100 % owned subsidiary, Evo Air Marketing, 55 % owned WKL EcoEarth Indochina,
and its 62.5 % owned WKL Guanzhe.
All
intercompany accounts and transactions have been eliminated in consolidation. In the opinion of the Management, the accompanying financial
statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements
in accordance with U.S. GAAP.
The
non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the stockholders of
the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations
and comprehensive loss as an allocation of the total loss for the year between non-controlling interest holders and the stockholders
of the Company.
11 | Page
Use
of Estimates
The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of sales and expenses during the reporting periods. Key estimates in the accompanying consolidated financial
statements include, among others, revenue recognition, allowances for credit losses and product returns, allowance for obsolete inventory,
valuation of long-lived assets and Rights of Use (“ROU”) assets (including lease liabilities), and deferred income tax asset
valuation allowances. Actual results could differ materially from these estimates.
Fiscal
Year End
The
Company operates on a fiscal year basis with the fiscal year ending on August 31.
Cash
and Cash Equivalents
The
Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents. The Company places its
cash with high credit quality financial institutions.
WKL
Guanzhe business is primarily conducted in China and substantially all of revenue are denominated in RMB. The government of People’s
Republic of China (“PRC”) imposes control over its foreign currency reserves in part through direct regulation of the conversion
of RMB into foreign exchange and through restrictions on foreign trade.
Comprehensive
Gain or Loss
ASC
220 “Comprehensive Income,” establishes standards for the reporting and display of comprehensive income and its components
in the financial statements. As of May 31, 2025, and August 31, 2024, the Company established that there are items that represented components
of comprehensive income and, therefore, has included a statement of comprehensive income in the financial statements.
Foreign
Currency Translation
The
functional currency of Chinese operations is Chinese Renminbi, (“RMB”). The functional currency of the Company’s Singapore
operations is Singapore dollars (“SGD”). The functional currency of the Company’s Malaysia operations is Ringgit Malaysia
(“RM”). Management has adopted ASC 830 “Foreign Currency Matters” for transactions that occur in foreign currencies.
Monetary assets denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Average
monthly rates are used to translate revenues and expenses.
Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination
of net income for the respective periods.
Assets
and liabilities of the Company’s operations are translated into the reporting currency, United States Dollars, at the exchange
rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods.
Equity transactions are recorded at the historical rate when the transaction occurred. The resulting translation adjustment is reflected
as accumulated other comprehensive income, a separate component of stockholders’ equity in the statement of stockholders’
equity.
Credit
Losses
In
June 2016, the FASB issued Accounting Standards Update (ASU) 2016-13, specifically Financial Instruments – Credit Losses (Topic
326), denoted as ASC 326. This regulatory framework supersedes the incurred loss methodology with the Current Expected Credit Loss (CECL)
methodology. CECL necessitates the derivation of credit loss estimates for the remaining projected life of financial assets, encompassing
historical data, prevailing conditions, and substantiated forecasts. Broadly applicable to financial assets assessed at amortized cost,
including trade receivables, loan receivables, and held-to-maturity debt securities, CECL also extends its purview to certain off-balance
sheet credit exposures, such as unfunded commitments to extend credit. In adherence to this methodology, financial assets measured at
amortized cost are to be presented on financial statements at the net amount anticipated to be collected, incorporating an allowance
for credit losses as a means of accounting for the estimated credit losses. The Company adopted ASU 2016-13 on September 1, 2023, using
the modified retrospective method. See below allowance for credit losses for more information.
12 | Page
Accounts
Receivable and Allowance for Credit Losses
Accounts
receivable are recorded at the net value of the face amount less any allowance for expected credit loss. The allowance for expected credit
loss is the Company’s best estimate of the amount of probable credit losses in our existing accounts receivable. An allowance for
credit losses is recorded in the period when loss is probable based on an assessment of specific evidence indicating troubled collection,
historical experience, accounts aging and other factors. The Company reviews the allowance for credit losses on a regular basis, and
all past due balances are reviewed individually for collectability. An account receivable is written off after all collection effort
has ceased. Recoveries of receivables previously written off are recorded when received. Interest is not charged on past due accounts.
As
of May 31, 2025 and August 31, 2024, our accounts receivable amounted to $ 59,495 and $ 62,914 ,
respectively, with no allowance for credit losses.
Inventories
Inventories
consist primarily of finished goods, raw materials, and work-in-process (“WIP”) from WKL Eco Earth, WKL EcoEarth Indochina,
WKL Guanzhe, and EvoAir Manufacturing.
We
value inventories at the lower of cost or net realizable value. We determine the costs of inventory using the standard cost method, which
approximates actual cost based on a first-in, first-out method. All other costs, including administrative costs, are expensed as incurred.
Deposit,
prepayments, and other receivables
Deposit,
prepayments and other receivables are comprised of prepayments paid to vendors to initiate orders and prepaid services fees and are classified
as current assets if such amounts are to be recognized within one year from the balance sheet date.
Property,
Plant and Equipment
Property,
plant and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of
the related capitalized assets. Property and equipment are depreciated over 5 to 10 years.
SUMMARY
OF ESTIMATED USEFUL LIVES OF ASSETS
Useful
lives
Plant
and machineries
5
years
Office
equipment
5
years
Vehicles
5
years
Furniture
and equipment
10
years
Renovation
10
years
Repair
and maintenance costs are charged to expense as incurred. At the time of retirement or other disposition of property, plant and equipment,
the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in
operations.
13 | Page
Intangible
Assets and Other Long-Lived Assets
The
Company’s intangible assets consist of patents and trademarks related to assignments of intellectual properties by Dr. Low into
WKL Eco Earth Holdings under the IP Assignments as contemplated in Note 1. The intangible assets are recorded at fair market value and
are amortized using the straight-line method over an estimated life of 20 years for both patents and trademarks.
Long-lived
assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable.
Recoverability of these assets is measured by comparison of their carrying amounts to future undiscounted cash flows the assets are expected
to generate. If identifiable intangibles are considered to be impaired, the impairment to be recognized equals the amount by which the
carrying value of the assets exceeds its fair market value.
Revenue
Recognition
Revenue
is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration
that an entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature,
amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The Company does not disaggregate its
revenue streams as the economic factors underlying the contracts are similar and provide no significant distinction. The amount of revenue
that is recorded reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company
applies the following five-step model in order to determine this amount: (i) identification of the promised goods or services in the
contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct
in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv)
allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies
each performance obligation.
The
Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled
to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606
at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which
of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated
to the respective performance obligation when (or as) the performance obligation is satisfied.
Deferred
Revenue
The
Company collects customer deposits in advance for certain business contracts. These advance payments are initially recorded as deferred
revenue on the balance sheet. As of August 31, 2024, deferred revenue totaled $ 10,012 , with $ 5,979 was recognized as revenue during
the nine months ended May 31, 2025. As of May 31, 2025, the Company recorded a deferred revenue balance of $ 16,014 .
Deferred
Offering Costs
The
Company follows the requirements of the FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A —
“Expenses of Offering”. Deferred offering costs consist of underwriting, legal and other expenses incurred through the balance
sheet date that are directly related to the intended initial public offering (“IPO”). Deferred offering costs will be charged
to shareholders’ equity netted against the proceeds upon the completion of the IPO. Should the IPO prove to be unsuccessful, these
deferred costs, as well as additional expenses to be incurred, will be charged to operations. As of May 31, 2025, and August 31, 2024,
the Company deferred $ 3,210,094 and $ 449,576 of offering costs, respectively. Such costs will be deferred and will be offset against
the offering proceeds upon the completion of the IPO.
Leases
We
have entered into operating agreements primarily for office and factory. We determine if an arrangement is a lease at inception. For
all classes of underlying assets, we elect not to recognize right of use assets or lease liabilities when a lease has a lease term of
12 months or less at the commencement date and does not include an option to purchase the underlying asset that we are reasonably certain
to exercise. Operating lease assets and liabilities are included on our consolidated balance sheet as of May
31, 2025 .
14 | Page
Operating
lease assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest
rate used to determine the present value of the future lease payments is our incremental borrowing rate, because the interest rate implicit
in most of our leases is not readily determinable. Our incremental borrowing rate is estimated to approximate the interest rate on a
collateralized basis with similar terms and payments, and in the economic environments where the leased asset is located. Operating lease
assets also include any prepaid lease payments and lease incentives. Our lease terms include periods under options to extend or terminate
the lease when it is reasonably certain that we will exercise that option. We generally use the base, non-cancellable, lease term when
determining the lease assets and liabilities. Operating lease expense is recognized on a straight-line basis over the lease term.
Our
lease agreements generally contain lease and non-lease components. Non-lease components primarily include payments for maintenance and
utilities. We combine fixed payments for non-lease components with our lease payments and account for them together as a single lease
component, which increases the amount of our lease assets and liabilities.
Income
Taxes
The
Company utilizes ASC Topic 740, “Income Taxes,” which requires the recognition of deferred tax assets and liabilities for
the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. The Company
accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities
and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is “more likely-than-not”
that a deferred tax asset will not be realized.
The
Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in
the consolidated statements of operations.
Measurement
of Fair Value
The
fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in
an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities
are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the
quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on
the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined in the following three
categories:
Level
1: Quoted market prices in active markets for identical assets or liabilities.
Level
2: Observable market-based inputs or inputs that are corroborated by market data.
Level
3: Unobservable inputs that are not corroborated by market data.
Earnings
(Loss) per Share
The
Company computes basic and diluted earnings (loss) per share amounts in accordance with ASC Topic 260, “Earnings per Share.”
Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number
of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur
if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common
stock that could share in the earnings of the Company. As of May 31,
2025 , the Company has no potentially dilutive securities, such as options or warrants, currently
issued and outstanding.
Reclassification
Certain prior year amounts have been
reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.
Recently
Issued Accounting Pronouncements
In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which introduces more detailed
requirements for annual disclosures for income taxes. The ASU requires public business entities to present specific categories in the
income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09
also requires all entities to disclose the amounts of income taxes paid, net of refunds received, disaggregated by federal, state, and
foreign jurisdiction. The ASU is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the
effects, if any, that the adoption of ASU 2023-09 may have on its financial position, results of operations, cash flows, or disclosures.
In
November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures
(Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public business entities to disclose specific information
about certain costs and expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and
interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating
the effects, if any, that the adoption of ASU 2024-03 may have on its financial position, results of operations, cash flows, or disclosures.
There
are no other recently issued accounting pronouncements that have not yet been adopted that the Company considers material to its consolidated
financial statements.
NOTE
5 INVENTORIES
Inventories
consist of the following:
SCHEDULE
OF INVENTORIES
May
31, 2025
August
31, 2024
Finished
goods
$ 92,215
$ 334,917
Raw
materials and supplies
342,806
125,130
Total
$ 435,021
$ 460,047
NOTE
6 DEPOSIT, PREPAYMENTS AND OTHER RECEIVABLES
Deposit,
prepayments, and other receivables consists of the following:
SCHEDULE
OF DEPOSIT PREPAYMENTS AND OTHER RECEIVABLES
May
31, 2025
August
31, 2024
Deposits
and Prepayments
$ 47,439
$ 33,406
Other
receivables (Advances to suppliers)
34,743
81,400
Total
$ 82,182
$ 114,806
15 | Page
NOTE
7 PROPERTY, PLANT AND EQUIPMENT, NET
Property,
plant, and equipment consist of the following:
SCHEDULE
OF PROPERTY, PLANT AND EQUIPMENT
May
31, 2025
August
31, 2024
Plant
and machineries
$ 598,681
$ 601,405
Office
equipment
63,760
61,143
Vehicles
84,477
83,239
Furniture
and equipment
24,292
23,936
Renovation
126,115
121,700
Property, plant and equipment gross
897,325
891,423
Less:
Accumulated depreciation
( 618,374 )
( 533,645 )
Property,
plant and equipment, net
$ 278,951
$ 357,778
Depreciation
expense for the nine months ended May 31, 2025 ,
was $ 84,729 . Depreciation expense for the period ended May 31, 2024 , was $ 187,729 .
NOTE
8 – INTANGIBLE ASSETS
The
below table summarizes the identifiable intangible assets as of May
31, 2025 , and August 31, 2024:
SUMMARY OF INTANGIBLE ASSETS
May
31, 2025
August
31, 2024
Technology
1-Portable Air Cooler
$ 27,438,763
$ 27,438,763
Technology
2-Condensing Unit
55,709,004
55,709,004
Finite- lived intangible assets, gross
83,147,767
83,147,767
Less:
Technology-related intangible asset impairment
( 20,580,040 )
( 20,580,040 )
Adjusted
carrying amount
62,567,727
62,567,727
Less:
Accumulated amortization
( 13,793,626 )
( 11,086,369 )
Intangible
assets, net
$ 48,774,101
$ 51,481,358
Amortization
expenses for intangible assets for the nine months ended May
31, 2025 , and 2024 were $ 2,707,257 and $ 3,118,041 respectively.
NOTE
9 ACCOUNTS PAYABLE, ACCRUALS, AND OTHER PAYABLES
Accounts
payable and accruals, and other payables consist of the following:
SCHEDULE OF ACCOUNTS PAYABLES ACCRUALS AND OTHER PAYABLE
May
31, 2025
August
31, 2024
Accounts
payable
$ 136,229
$ 154,854
Accruals
145,833
113,046
Other
payables
164,411
95,831
Total
$ 446,473
$ 363,731
NOTE
10 RELATED PARTY TRANSACTIONS
Amounts
due to shareholders
Amounts
due to shareholders are unsecured loans bearing 3% annual interest, with a six-month term or as mutually agreed by the parties.
The Company reported amount due to
shareholders of $ 2,174,737 and
$ 1,202,692 as
of May 31, 2025 ,
and August 31, 2024, respectively.
16 | Page
NOTE
11 STOCKHOLDERS’ EQUITY
On
December 16, 2021, the Company increased the authorized common stock from 75,000,000 shares with a par value of $ 0.001 per share to 1,000,000,000
shares with a par value of $ 0.001 per share.
During
the nine months period ended May 31, 2024, the Company issued 373,822 shares of Common Stock at a per share purchase price of $ 2.50 as
the Offering for gross proceeds of $ 934,534 received in the fiscal year ended August 31,2023.
During
the nine months period ended May 31, 2024, the Company issued in aggregate 52,107 shares of Common Stock to 15 referral agents in consideration
for their referral to the Company of certain investors.
On
November 21, 2023, the Company issued, in aggregate, 5,500 shares of Common Stock to two individuals in consideration for marketing services
provided to the Company by Artisan Creative Studio, a marketing entity based in Malaysia.
On
April 12, 2024, the Company’s board of directors unanimously resolved to effect a reverse stock split of the Company’s common
stock, par value $ 0.001 per share, at a ratio of 1-for-4. Following such resolution, on September 9, 2024, the Company filed a Certificate
of Amendment with the Secretary of State of the State of Nevada to effect the reverse stock split, with effective on September 11, 2024.
On
November 25, 2024, the Company issued, in aggregate, 679,516 shares of Common Stock, representing 2.5 % of the issued and outstanding
shares of Common Stock, to certain project management consultant in consideration for their services in relation to the proposed initial
public offering.
On
November 25, 2024, the Company issued, in aggregate, 815,419 shares of Common Stock, representing 3.0 % of the issued and outstanding
shares of Common Stock in consideration for their corporate and business development consulting services.
As
a result of the 1:4 Reverse Stock Split, each 4 pre-split shares of Common Stock outstanding will automatically combine into one new
share of Common Stock without any action on the part of the holders. Therefore, as of May 31, 2025, and August 31, 2024, the Company
had 27,180,631 and 25,685,591 shares of its common stock issued and outstanding, respectively.
NOTE
12 INCOME TAXES
The
Company’s operating subsidiaries are governed by the Income Tax Law (defined hereunder), which concerns Foreign Investment Enterprises
and Foreign Enterprises and various local income tax laws (“Income Tax Laws”). We routinely undergo examinations in the jurisdictions
in which we operate.
The
Company has operations in Singapore, Malaysia, Cambodia, BVI, and China that are subject to taxes in the jurisdictions in which they
operate, as follows:
Singapore
WKL
Eco Earth Holdings is incorporated in Singapore, and under the current tax laws of Singapore, its standard corporate income tax rate
is 17 %.
Malaysia
WKL
Eco Earth, WKL Green Energy and Evoair Manufacturing (including its 100 % subsidiary Evo Air Marketing) are incorporated in Malaysia and
are subject to common corporate income tax rate at 24 %.
Cambodia
WKL
EcoEarth Indochina is incorporated in Cambodia, and under the current tax laws of Cambodia, its standard corporate tax rate is 20 %.
17 | Page
BVI
EvoAir
International is incorporated in BVI, and a BVI Business Company is exempt from the BVI income tax.
China
WKL
Guanzhe is incorporated in China. Under the current tax law in the PRC, WKL Guanzhe is subject to the enterprise income tax rate of 25 %.
Due
to the Company’s net loss position, there was no provision for income taxes recorded. As a result of the Company’s losses
to date, there exists doubt as to the ultimate realization of the deferred tax assets. Accordingly, a valuation allowance equal to the
total deferred tax assets has been recorded.
Reconciliation
between the statutory tax rate to income before income taxes and the actual provision for income taxes is as follows:
SCHEDULE OF RECONCILIATION BETWEEN THE STATUTORY TAX RATE AND THE ACTUAL PROVISION
Nine
Months Ended
May
31, 2025
May
31, 2024
US
Statutory rate
21 %
21 %
Effect
of reconciling items for tax purposes
( 21 )%
( 21 )%
Effective
income tax rate
- %
- %
The
components of net deferred tax assets are as follows:
SCHEDULE OF COMPONENTS OF NET DEFERRED TAX ASSETS
May
31, 2025
August
31, 2024
Net
operating loss carry-forward
$ 46,300,000
$ 39,400,000
Less:
valuation allowance
( 46,300,000 )
( 39,400,000 )
Net
deferred tax asset
-
-
The
Company had net operating loss carry forwards for tax purposes of approximately $ 46,300,000 as of May 31, 2025, and approximately $ 39,400,000
as of August 31, 2024, which may be available to offset future taxable income. Utilization of the net operating loss carry forwards may
be subject to substantial annual limitations due to the ownership change limitations provided by Section 381 of the Internal Revenue
Code of 1986, as amended. The annual limitation may result in the expiration of net operating loss carry forwards before utilization.
NOTE
13 ROU ASSET AND LEASES
A
lease is defined as a contract that conveys the right to control the use of identifiable tangible property for a period of time in exchange
for consideration. The Company adopted ASC Topic 842 which primarily affected the accounting treatment for operating lease agreements
in which the Company is the lessee including the Company’s leases of office and factory. The Company elected to not recognize ROU
assets and lease liabilities arising from short-term leases with initial lease terms of twelve months or less (deemed immaterial) on
the accompanying consolidated balance sheets.
ROU
assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Lease expense for minimum
lease payments is recognized on the effective interest, the effective amortization on the lease liability. The lease terms may include
options to extend or terminate the lease if it is reasonably certain that the Company will exercise that option.
When
measuring lease liabilities for leases that were classified as operating leases, the Company discounted lease payments using its estimated
incremental borrowing rate of 10 %.
18 | Page
On
March 28, 2023, the Company entered into a lease termination agreement to its Cambodia office lease at #65, 1st, 2nd and 3rd Floor, Street
123, Sangkat Toul Tumpong I, Khan Chamkarman, Phnom Penh, Cambodia (the “Lease Termination”). The Lease Termination terminated
the Company’s rights and obligations with respect to the leased premises on April 15, 2023. As such, the ROU assets and operating
lease liabilities were remeasured, and the Company recorded a gain of $ 14,890 as a component of operating expenses for the year ended
August 31, 2023. No impairment of the ROU assets was deemed to have occurred.
The
following is a summary of ROU asset and operating lease liabilities:
SUMMARY OF ROU ASSET AND OPERATING LEASE LIABILITIES
May
31, 2025
August
31, 2024
Assets:
ROU
asset
$ 138,640
$ 199,647
Liabilities:
Current:
Operating
lease liabilities
$ 97,619
$ 99,445
Operating lease liabilities current
$ 97,619
$ 99,445
Non-current
Operating
lease liabilities
46,870
108,891
Operating
lease liabilities non current
46,870
108,891
Total
lease liabilities
$ 144,489
$ 208,336
Operating
lease liabilities
$ 144,489
$ 208,336
As
of May 31, 2025, the remaining maturities of lease liabilities were as follows:
SCHEDULE OF MATURITIES OF LEASE LIABILITIES
Operating
lease
2026
$ 97,619
2027
46,870
Total
$ 144,489
NOTE
14 COMMITMENTS AND CONTINGENCIES
In
the normal course of business, we are subject to the effects of certain contractual stipulations, events, transactions, and laws and
regulations that may, at times, require the recognition of liabilities. We establish estimated liabilities when the associated costs
related to uncertainties or guarantees become probable and can be reasonably estimated. For the period ended May 31, 2025,
there were no significant changes to our estimated liabilities from those reported in the Commitments and Contingencies note of the condensed
consolidated financial statements in our Form 10-Q.
NOTE
15 SUBSEQUENT EVENTS
In
accordance with FASB ASC 855-10 Subsequent Events, the Company has analyzed its operations subsequent to May 31, 2025, to the date these
consolidated financial statements were issued, and has determined that it does not have any material subsequent events to disclose in
these consolidated financial statements.
19 | Page
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-looking
Statements
This
Quarterly Report contains forward-looking statements relating to future events or our future financial performance. In some cases, you
can identify forward-looking statements by terminology such as “may”, “should”, “intends”, “expects”,
“plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”,
or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve
known and unknown risks, uncertainties and other factors which may cause our or our industry’s actual results, levels of activity
or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking
statements.
Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity or performance. You should not place undue reliance on these statements, which speak only as of the date that they were made.
These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future.
Except as required by applicable law, including the securities laws of the U.S., we do not intend to update any of the forward-looking
statements to conform these statements to actual results, later events or circumstances or to reflect the occurrence of unanticipated
events.
In
this report unless otherwise specified, all dollar amounts are expressed in US$ and all references to “common shares” or
“common stock” refer to the common shares of our capital stock.
The
management’s discussion and analysis of our financial condition and results of operations are based upon our financial statements,
which have been prepared in accordance with U.S. GAAP.
General
Overview
EvoAir
Holdings Inc (formerly Unex Holdings Inc.) (the “Company”, “EVOH”, “we”, “us”, or “our”)
is a corporation established under the corporation laws in the State of Nevada, U.S. on February 17, 2017. The Company has adopted an
August 31 fiscal year end.
On
December 20, 2021, the Company and Dr. Low entered into the EvoAir International Share Transfer Agreement, pursuant to which Dr. Low
agreed to sell all of his ordinary shares of EvoAir International to the Company for the consideration of US$100 (“EvoAir Transaction”).
EvoAir International, through its subsidiaries upon completion of the Transactions contemplated under Note 1 to Financial Statements,
is engaged in the R&D, manufacturing, trading, sale of HVAC products and related services in Asia.
Pursuant
to the terms of a share transfer agreement dated December 20, 2021, Dr. Low, the then sole executive officer and director of the Company
and the owner of 2,000,000 restricted shares of the Company’s ordinary shares representing approximately 67.34% of the Company’s
then issued and outstanding shares, sold his entire shareholding of the Company to WKL Global for an aggregate consideration of $100.
Upon completion of the Change of Control Transaction, WKL Global owned 2,000,000 shares, or approximately 67.34% of the then issued and
outstanding ordinary shares of the Company, which resulted in a change of control of the Company.
On
December 20, 2021, several transactions took place (together, the “Allotment Transactions”) whereby the Company issued and
allotted in aggregate 98,809,323 EvoAir Shares to certain parties. On completion of the Allotment Transactions, the total number of issued
and outstanding EvoAir Shares were 101,779,323 (“Then Enlarged Share Capital”):
(A)
On December 20, 2021, Dr. Low and Chan Kok Wei entered into a share exchange agreement with WKL Eco Earth Holdings, pursuant to which
Dr. Low and Chan Kok Wei agreed to sell all their ordinary shares of WKL Green Energy to WKL Eco Earth Holdings in consideration for
the allotment and issuance to WKL Global and Allegro Investment (BVI) Limited (“Allegro Investment”), a company incorporated
in the British Virgin Islands with 50% shareholding held by Chan Kok Wei and Ong Bee Chen, respectively, of 24,000 EvoAir Shares and
6,000 EvoAir Shares, respectively, or approximately 0.02% and 0.01% of the Then Enlarged Share Capital, respectively.
20 | Page
(B)
On December 20, 2021, Dr. Low, Chan Kok Wei, Ong Bee Chen and certain sellers (collectively, the “WKLEE Sellers”) entered
into a share exchange agreement with WKL Eco Earth Holdings, pursuant to which the WKLEE Sellers agreed to sell all their ordinary shares,
amounting in aggregate, 240,000 shares or 80% shareholding of WKL Eco Earth to WKL Eco Earth Holdings in consideration for the allotment
and issuance to WKL Global, Allegro Investment and WKLEE Sellers of 49,320 EvoAir Shares, 8,280 EvoAir Shares and in aggregate 14,400
EvoAir Shares, respectively, or approximately 0.05%, 0.009% and in aggregate 0.014%, respectively, of the Then Enlarged Share Capital.
(C)
On December 20, 2021, Tan Soon Hock, Ivan Oh Joon Wern and certain relevant interest holders (“Relevant Interest Holders”)
entered into an investment exchange agreement with WKL Eco Earth Holdings, pursuant to which the Tan Soon Hock, Ivan Oh Joon Wern and
the Relevant Interest Holders agreed to sell all relevant interests in the EvoAir Group to WKL Eco Earth Holdings in consideration for
the allotment and issuance of 7,037,762 shares, 2,520,000 shares and in aggregate 6,001,794 shares, respectively, of the common stock
of the Company, or approximately 6.91%, 2.48% and in aggregate 5.90%, respectively, of the issued and outstanding ordinary shares of
the Company. The board of directors and majority shareholders of the Company have approved the transaction.
(D)
On December 20, 2021, Dr. Low entered into two deeds of assignment of intellectual properties with WKL Eco Earth Holdings, in respect
of Dr. Low’s patents relating to eco-friendly air-conditioner condenser (external unit), EvoAir TM and the trademarks
described in the deed of assignment thereunder, and in respect of Dr. Low’s patents relating to the portable air-conditioner, e-Cond
EVO TM and the trademarks as described in the deed of assignments thereunder (together, the “IP Assignments”).
Pursuant to the IP Assignments, WKL Global, Allegro Investment and certain nominees shall be allotted and issued 63,362,756 EvoAir Shares,
14,297,259 EvoAir Shares and in aggregate 5,487,752 EvoAir Shares, respectively or approximately 62.25%, 14.05% and in aggregate 5.39%,
respectively of the Then Enlarged Share Capital in consideration for the IP Assignments.
EvoAir
Transaction, Change of Control Transaction and Allotment Transactions are collectively to be referred to as the “Transactions”.
The closing of the Transactions (the “Closing”) occurred on December 20, 2021 (the “Closing Date”).
From
and after the Closing Date, at which time EvoAir International transferred its HVAC business to the Company, the Company’s primary
operations consisted of the prior operations of EvoAir International.
EvoAir
International is a company incorporated in BVI on November 17, 2021. Effective from the December 20, 2021, it wholly owns WKL Eco Earth
Holdings, a company incorporated in Singapore on July 12, 2018, which in turn wholly owns (a) WKL Eco Earth, a Malaysian company incorporated
on May 17, 2017, and (b) WKL Green Energy a Malaysian company incorporated on October 24, 2017. WKL Eco Earth Holdings acquired (c) EvoAir
Manufacturing on April 19, 2021, a Malaysian company incorporated on March 22, 2019, as well as acquiring (d) WKL EcoEarth Indochina,
a Cambodia company incorporated on February 4, 2021, (e) WKL Guanzhe Green Technology Guangzhou, a Chinese company incorporated on April
6, 2021. EvoAir Manufacturing wholly owns (f) Evo Air Marketing, a Malaysian company incorporated on February 2, 2021.
On
June 15, 2022, the Company filed a Certificate of Amendment (the “Amendment”) to the Articles of Incorporation with Nevada’s
Secretary of State to change the name of the Company from Unex Holdings Inc. to EvoAir Holdings Inc. (the “Name Change”),
and the Name Change became market effective on November 4, 2022. Effective on November 11, 2022, the Company’s shares began trading
under the new ticker symbol “EVOH”.
On
November 21, 2023, the Company issued in aggregate, 52,107 shares of Common Stock to 15 referral agents (“Referral Agents”)
in consideration for their referral to the Company of certain investors. Each Referral Agent is a “non-U.S. Persons” as defined
in Regulation S.
On
November 21, 2023, the Company issued, in aggregate, 5,500 shares of Common Stock to two individuals in consideration for marketing services
provided to the Company by Artisan Creative Studio, a marketing entity based in Malaysia. Each of the individuals is a “non-U.S.
Persons” as defined in Regulation S.
21 | Page
Round
2 Stockholders
The
Company entered into a series of offerings for an aggregate of up to 6,000,000 shares of Common Stock at a per share purchase price of
$2.50, as follows:
●
On
February 15, 2022, the Company entered into certain share subscription agreement with Ms. Ang Lee Kim Jane, who is a “non-U.S.
Persons” (the “Investor”) as defined in Regulation S of the Securities Act of 1933, as amended (the “Securities
Act”) pursuant to which the Company agreed to issue and sell 74,074 Shares, par value $0.001 per share, at a per share purchase
price of $2.50, as part of a series of offerings by the Company for an aggregate of up to 6,000,000 shares of Common Stock at a per
share purchase price of $2.50. The gross proceeds were $185,185.
●
On
June 3, 2022, the Company entered into certain share subscription agreement with Mr. Wong Hon Wai who is a “non-U.S. Persons”
(the “Investor”) as defined in Regulation S of the Securities Act of 1933, as amended (the “Securities Act”)
pursuant to which the Company agreed to issue and sell 5,000 shares, par value $0.001 per share , at a per share purchase price of
$2.50, as part of a series of offerings by the Company for an aggregate of up to 6,000,000 shares of Common Stock at a per share
purchase price of $2.50. The gross proceeds were $12,500.
●
On
October 25, 2022, the Company entered into Regulation S share subscription agreements with eight investors, each of whom represented
that it was a “non-U.S. Persons” as defined in Securities Act. On the same date, the Company entered into Regulation
D share subscription agreements with two investors, each of whom represented that it was an “Accredited Investors” as
defined in Regulation D of the Securities Act. Pursuant to the share subscription agreements, the Company agreed to issue and sell
in aggregate, (i) 129,621 shares of Common Stock, par value $0.001 per share to the Regulation S investors, and (ii) 15,000 shares
of Common Stock to the Regulation D investors, respectively par value $0.001 per share, at a per share purchase price of $2.50, as
part of a series of offerings by the Company for an aggregate of up to 6,000,000 shares of Common Stock at a per share purchase price
of $2.50. The gross proceeds in aggregate were $361,553.
●
On
February 20, 2023, the Company entered into Regulation S share subscription agreements with eleven investors, each of whom represented
that it was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the agreements, the Company
agreed to issue and sell in aggregate, (i) 57,783 shares of Common Stock, par value $0.001 per share to the Regulation S investors,
at a per share purchase price of $2.50 as part of a series of the private placement offerings by the Company for an aggregate of
up to 6,000,000 shares of Common Stock at a per share purchase price of $2.50. The gross proceeds in aggregate were $144,443.
●
On
July 13, 2023, the Company entered into Regulation S share subscription agreements with 31 investors, each of whom represented that
it was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the agreements, the Company
agreed to issue and sell in aggregate, (i) 250,132 shares of Common Stock, par value $0.001 per share to the Regulation S Investors,
at a per share purchase price of $2.50 as part of a series of the private placement offerings by the Company for an aggregate of
up to 6,000,000 shares of Common Stock at a per share purchase price of $2.50. The gross proceeds in aggregate were approximately
$625,330.
●
On
September 7, 2023, the Company entered into Regulation S share subscription agreements with 71 investors, each of whom represented
that it was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the agreements, the Company
agreed to issue and sell in aggregate, 365,164 shares of Common Stock, par value $0.001 per share to the Regulation S investors,
at a per share purchase price of $2.50 as part of a series of the private placement offerings by the Company for an aggregate of
up to 6,000,000 shares of Common Stock at a per share purchase price of $2.50. The gross proceeds in aggregate was approximately
$912,889.
●
On
November 21, 2023, the Company entered into a Regulation S share subscription agreement with Wong Chun Shoong who represented that
he was a “non-U.S. Persons” as defined in Regulation S of the Securities Act. Pursuant to the agreement, the Company
agreed to issue and sell in aggregate, 8,658 shares of Common Stock, par value $0.001 per share to the Regulation S investors, at
a per share purchase price of $2.50 as part of a series of the private placement offerings by the Company for an aggregate of up
to 6,000,000 shares of Common Stock at a per share purchase price of $2.50. The gross proceeds in aggregate was approximately $21,645.
22 | Page
Reverse
Stock Split
On
April 12, 2024, the Company’s board of directors (the “Board”) unanimously resolved to effect a reverse stock split
of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-4. Following such
resolution, on September 9, 2024, the Company filed a Certificate of Amendment (the “Certificate of Amendment”) with the
Secretary of State of the State of Nevada to effect the reverse stock split, with an effective time of 9:00AM. Eastern Time on September
11, 2024 (the “Reverse Stock Split”).
Split
Adjustment; Treatment of Fractional Shares
As
a result of the 1:4 Reverse Stock Split, each 4 pre-split shares of Common Stock outstanding will automatically combine into one new
share of Common Stock without any action on the part of the holders, and the number of outstanding shares of Common Stock was reduced
from 102,742,362 shares to 25,685,591 shares (subject to rounding up of fractional shares to the nearest whole number).
No
fractional shares were issued in connection with the Reverse Stock Split. Fractional shares were rounded up to the nearest whole number
Share
Issuance
On
November 25, 2024, the Company issued, in aggregate, 679,516 shares of Common Stock, representing 2.5% of the issued and outstanding
shares of Common Stock to certain project management consultant in consideration for their services in relation to proposed initial public
offering.
On
November 25, 2024, the Company issued, in aggregate, 815,419 shares of Common Stock, representing 3.0% of the issued and outstanding
shares of Common Stock to certain corporate and business consultant in consideration for their consulting services.
Plan
of Operation and Funding
We
expect that working capital requirements will continue to be funded through internally generated funds and proceeds from issuances of
securities. Our working capital requirements are expected to increase in line with the growth of our business.
Existing
working capital, proceeds from issuance of securities, further advances, and anticipated cash flow are expected to be adequate to fund
our operations over the next twelve months. We have no lines of credit or other bank financing arrangements. Generally, we have financed
operations to date through internally generated funds, advances and proceeds from issuance of securities. In connection with our business
plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) research and development;
(ii) expansion of product offerings; (iii) geographical expansion; and (iv) marketing expenses. We intend to finance these expenses with
further issuances of securities and advances. Thereafter, we expect we will need to raise additional capital and generate revenue to
meet long-term operating requirements. Additional issuances of equity will result in dilution to our current shareholders. Further, such
securities might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available upon acceptable
terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage
of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.
Results
of Operations
The
following summary of our operations should be read in conjunction with our unaudited condensed consolidated financial statements for
the three and nine months ended May 31, 2025, as compared to the three and nine months ended May 31, 2024.
23 | Page
Three
Months Ended May 31, 2025, versus Three Months May 31, 2024.
Three Months Ended May 31
2025
2024
Changes
%
Revenue
$ 37,306
$ 89,616
$ (52,310 )
(58 )%
Cost of revenue
8,505
56,741
(48,236 )
(85 )%
Gross profit
28,801
32,875
(4,074 )
(12 )%
Operating expenses
1,237,464
1,007,694
229,770
23 %
Loss from operation
(1,208,663 )
(974,819 )
(233,844 )
(24 )%
Other income
21,825
378
21,447
5674 %
Loss from operation before income taxes
$ (1,186,838 )
$ (974,441 )
(212,397 )
(22 )%
Revenue
The
Group generated revenues of $37,306 in the three months ended May 31, 2025, as compared to $89,616 in the three months ended May 31,
2024. The decrease of $52,310 was primarily due to reduction in sales of EvoAir™
air-conditioner.
We
are steadily building momentum and expanding the product’s reach across various markets, including residential, commercial, and
industrial sectors. This is being achieved through the development of strategic distribution channels, project collaborations, and private
labelling and licensing models. The Group remains committed to strengthening the traction of EvoAir™ air-conditioner and driving
its adoption across diverse market segments, positioning ourselves for future growth in the emerging eco-friendly air-conditioning space.
We
remain confident in the long-term prospects of EvoAir™ and are focused on continuing to innovate and address challenges, with a
view to establishing the product as a leading solution in the sustainable cooling market.
Cost
of revenue
For
the three months ended May 31, 2025, cost of revenue decreased to $8,505, or 23% of revenue, compared to $56,741, or 63% of revenue in
the same period in 2024. The significant decrease in the cost of revenue as a percentage of sales was primarily driven by the lower production
costs of the Ionic Nano Copper Zinc solution.
The
cost of revenue encompasses production costs and purchase of goods. The Company remains focused on further optimizing its cost structure
and maintaining efficiencies as it continues to scale its operational and expand its product offering.
Gross
profit
For
the three months ended May 31, 2025, the Company reported a gross profit of $28,801 or a gross margin of 77%, compared to a gross profit
of $32,875, or a gross profit margin of 37% in the same period in 2024. The significant improvement in gross profit margin was primarily
driven by the better margins achieved from the sale of the Ionic Nano Copper Zinc solution, which has contributed positively to our overall
profitability.
The
Company remains focused on optimizing its cost structure and enhancing operational efficiencies. As we continue to scale operations and
expand our product offerings, we are positive that these efforts will improve gross margins and position the Company for profitability
in the future.
Operating
expenses
For
the three months ended May 31, 2025, operating expenses amounted to $1,237,464, compared to $1,007,694 in the same period in 2024, reflecting
an increase of $229,770. This increase was primarily driven by the increased general and administrative expenses net with the reduction
in technology-related intangible asset amortization following the impairment of intangible assets in the year ended August 31, 2024.
24 | Page
Key
components of operating expenses included salaries and related expenses, commissions, rental costs, patent and trademark application/renewal
fees, professional and compliance fees.
The
Company remains focused on prudent cost management to maintain operational efficiency while supporting strategic initiatives for growth
and value creation.
Other
income
Other
income for the three months ended May 31, 2025, and 2024 were not material.
Loss
from operations before income taxes
The
Company reported a loss from operations before income taxes of $1,186,838 for the three months ended May 31, 2025, compared to $974,441
in the corresponding period in 2024.
The
continued net loss is primarily attributable to the Company’s strategic investments in building the necessary infrastructure and
resources to support its business expansion objectives. Additionally, the lack of economies of scale during this growth phase has impacted
the bottom line.
Management
remains confident that these investments will position the Company for long-term growth and profitability as it scales operations and
capitalizes on emerging opportunities. Strategies to enhance operational efficiencies and achieve economies of scale are key priorities
moving forward.
Nine
Months Ended May 31, 2025, versus Nine Months May 31, 2024.
Nine Months Ended May 31
2025
2024
Changes
%
Revenue
$ 160,359
$ 222,108
$ (61,749 )
(28 )%
Cost of revenue
168,681
244,142
(75,461 )
(31 )%
Gross loss
(8,232 )
(22,034 )
13,712
62 %
Operating expenses
7,116,685
3,998,445
3,118,240
78 %
Loss from operation
(7,125,007 )
(4,020,479 )
(3,104,528 )
(77 )%
Other income
24,277
90,959
(66,682 )
(73 )%
Loss from operation before income taxes
$ (7,100,730 )
$ (3,929,520 )
(3,171,210 )
(81 )%
Revenue
The
Group generated revenues of $ 160,359 in the nine months ended May 31, 2025, as compared to $222,108 in the nine months ended May 31,
2024, a decrease in revenue of $61,749. The overall revenue decrease of $61,000 was mainly driven by significant
reduction in EvoAir air-conditioners sales. However, this decline was mitigated by increased in sales of Ionic Nano Copper Zinc Solution.
While
the reduction in EvoAir™ air-conditioner sales impacted overall revenue, the growth in sales of the Ionic Nano Copper Zinc solution
provided a partial cushion, contributing positively to the Group’s financial performance. The Group remains focused on driving
the adoption of both products, and efforts to enhance the performance of EvoAir™ are ongoing, alongside continued expansion of
the Ionic Nano Copper Zinc solution’s market presence.
We
are confident that strategic initiatives in both product segments will enable the Group to regain momentum and drive growth in the coming
quarters.
We
are steadily building momentum and expanding the product’s reach across various markets, including residential, commercial, and
industrial sectors. This is being achieved through the development of strategic distribution channels, project collaborations, and private
labelling and licensing models. The Group remains committed to strengthening the traction of EvoAir™ and driving its adoption across
diverse market segments, positioning ourselves for future growth in the emerging eco-friendly air-conditioning space.
25 | Page
We
are confident that strategic initiatives in both product segments will enable the Group to regain momentum and drive growth in the coming
quarters.
Cost
of revenue
For
the nine months ended May 31, 2025, cost of revenue increased to $168,681, or 105% of revenue, compared to $244,142 or 110% in the same
period in 2024. This change in cost of revenue is consistent with the change in sales.
The
cost of revenue encompasses production costs and purchase of goods. The Company remains focused on further optimizing its cost structure
and maintaining efficiency as it continues to scale its operational and expand its product offering.
Gross
loss
For
the nine months ended May 31, 2025, the Company reported a gross loss of $8,322 or a gross loss margin of 5%, compared to a gross loss
of $22,034 or negative gross profit margin of 10% in the same period in 2024. The improvement in gross loss margin was primarily driven
by the better margins achieved from the sale of the Ionic Nano Copper Zinc solution.
The
Company remains focused on optimizing its cost structure and enhancing operational efficiencies. As we continue to scale operations and
expand our product offerings, we are positive that these efforts will improve gross margins and position the Company for profitability
in the future.
Operating
expenses
For
the nine months ended May 31, 2025, operating expenses amounted to $7,116,685, compared to $3,998,445 in the same period in 2024, reflecting
an increase of $3,118,240. This increase was primarily driven by a $3,261,676 rise in stock-based compensation, partially offset by a
reduction in technology-related intangible asset amortization following the impairment of intangible assets in the year ended August
31, 2024.
Key
components of operating expenses included salaries and related expenses, commissions, rental costs, patent and trademark application/renewal
fees, professional and compliance fees.
The
Company remains focused on prudent cost management to maintain operational efficiency while supporting strategic initiatives for growth
and value creation.
Other
income
Other
income decreased, mainly due to the decrease in realized foreign exchange gain from the amount due to shareholders’ wires in period
ended May 31, 2024.
Loss
from operations before income taxes
The
Company reported a loss from operations before income taxes of $7,100,730 for the nine months ended May 31, 2025, compared to $3,929,520
in the corresponding period in 2024.
The
continued net loss is primarily attributable to the Company’s strategic investments in building the necessary infrastructure and
resources to support its business expansion objectives. Additionally, the lack of economies of scale during this growth phase has impacted
on the bottom line.
Management
remains confident that these investments will position the Company for long-term growth and profitability as it scales operations and
capitalizes on emerging opportunities. Strategies to enhance operational efficiencies and achieve economies of scale are key priorities
moving forward.
26 | Page
Liquidity
and Capital Resources
Working
Capital
As of
As of
May 31, 2025
August 31, 2024
Changes
%
Current assets
$ 657,714
$ 790,752
$ (133,038 )
(17 )%
Current liabilities
2,741,918
1,684,638
1,057,280
63 %
Working capital
(2,084,204 )
(893,886 )
(1,190,318 )
(133 )%
As
of May 31, 2025, the decrease in current assets was mainly due to the decrease in cash, and prepayments.
As
of May 31, 2025, the increase in current liabilities was mainly due to the increase in amount due to shareholders of $972,045.
As
of May 31, 2025, our company had a working capital deficit of $2,084,204, compared with $893,886 as of August 31, 2024.
Cash
Flows
Nine
Months Ended May 31, 2025, versus Nine Months Ended May 31, 2024
May 31,
May 31,
2025
2024
Changes
%
Cash flows used in operating activities
$ (900,095 )
$ (595,059 )
(305,036 )
(51 )%
Cash flows used in investing activity
(5,902 )
(102,414 )
96,512
94 %
Cash flows generated from financing activities
923,588
134,724
788,864
586 %
Net changes in cash
17,591
(562,749 )
580,340
103 %
The
Company’s cash and cash equivalents stood at $81,016 as of May 31, 2025. Cash used in operating activities for the nine months
ended May 31, 2025, was $900,095. This resulted primarily from a net loss of $7,100,730 which was offset by depreciation of $84,729, amortization
of $ 2,707,257, stock-based expense of $$3,261,676, decrease in operating lease right-of-use assets of $61,007, decrease in operating
leases liabilities of $63,847, decrease in inventories of $25,026, increase in deferred revenue of $ 6,002, decrease in deposit, prepayment
and other receivables of $32,624, decrease in accounts receivable of $3,419, increase in accounts payable and accruals of $14,162, and increase in other payables of $68,580.
Cash used in investing activities resulted in purchase of property, plant
and equipment amounting to $5,902 during the nine months ended May 31, 2025.
Cash generated from financing activities resulted in proceeds from shareholders
of $972,045, payments of hire purchase amounting to $6,003 and deferred offering costs of $42,454 during the nine months ended May 31,
2025.
Seasonality
The
Company’s business is not subject to seasonality.
Off-Balance
Sheet Arrangements
As
of the date of this Quarterly Report on Form 10-Q, we do not have any off-balance sheet arrangements that have or are reasonably likely
to have a current or future effect on our financial condition, changes in financial condition, revenue or expenses, results of operations,
liquidity, capital expenditures or capital resources that are material to investors.
27 | Page
Critical
Accounting Policies
Revenue
recognition
Our
revenue recognition policy is in compliance with ASC 606, Revenue from Contracts with Customers that revenue is recognized when
a customer obtains control of promised goods and is recognized in an amount that reflects the consideration that we expect to receive
in exchange for those goods. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue
and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that we expect
to receive in exchange for those goods.
We
apply the following five-step model in order to determine this amount:
(i)
identification
of the promised goods and services in the contract;
(ii)
determination
of whether the promised goods and services are performance obligations, including whether they are distinct in the context of the
contract;
(iii)
measurement
of the transaction price, including the constraint on variable consideration;
(iv)
allocation
of the transaction price to the performance obligations; and
(v)
recognition
of revenue when (or as) the Company satisfies each performance obligation.
We
only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange
for the goods or services we transfer to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception,
we review the contract to determine which performance obligations we must deliver and which of these performance obligations are distinct.
We recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when the performance
obligation is satisfied or as it is satisfied. Generally, our performance obligations are transferred to customers at a point in time,
typically upon delivery for local sales and upon shipment of the products for export sale.
For
all reporting periods, we have not disclosed the value of unsatisfied performance obligations for all product revenue contracts with
an original expected length of one year or less, which is an optional exemption that is permitted under the adopted rules.
Estimates
and Assumptions
The
preparation of financial statements in conformity with U.S. GAAP requires the Management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of sales and expenses during the reporting periods. Key estimates in the accompanying unaudited condensed consolidated
financial statements include, inter-alia , revenue recognition, allowances for doubtful accounts and product returns, provisions
for obsolete inventory, valuation of long-lived assets and rights of use (“ROU”) assets (including lease liabilities), and
deferred income tax asset valuation allowances. The actual results could differ materially from these estimates.
Going
Concern
The
Company’s financial statements as of May 31, 2025, is prepared using generally accepted accounting principles in the United States
of America (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities
in the normal course of business. The Company has not yet established a sustainable ongoing source of revenue sufficient to cover its
operating costs and allow it to continue as a going concern.
As
of May 31, 2025, the Company had an accumulated deficit of $46,280,904 and a working capital deficiency of $2,084,204. As of
August 31, 2024, the accumulated deficit was $39,401,857 and the working capital deficiency
was $893,886. The Company incurred net loss of $7,100,730 and $3,929,520 for the nine months ended May 31, 2025, and 2024, respectively.
The cash used in operating activities was $900,095 for the nine months ended May 31, 2025, and the cash used in operating activities
was $595,059 for the nine months ended May 31, 2024, respectively. It was brought to the attention of the Management to assess going
concern considering all facts and circumstances about the foreseeable future of the Company as well as its assets and liabilities on
the basis that it will be able to realize and discharge them in the normal course of business.
28 | Page
To
address these challenges and ensure the Company’s long-term viability, Management has developed a strategic plan focused on the
continued development and expansion of its HVAC business. Key initiatives include:
●
Expansion
of Product Offerings: Broadening the range of HVAC products to meet diverse market needs.
●
Geographical
Expansion: Penetrating new markets to drive revenue growth.
●
Revenue
Diversification: Expanding customer segments across retail, commercial, industrial, and project-based clients, as well as private
label and licensing opportunities.
●
Improved
Profitability: Achieving economies of scale through operational efficiencies and growth.
Additionally,
the Company is actively pursuing plans to raise additional funding to support operations and business expansion. This includes preparations
to uplist on the Nasdaq Capital Market, which is expected to enhance access to capital and further strengthen the Company’s financial
position.
The
consolidated financials have been prepared assuming that the Company will continue as a going concern and accordingly financial statements
do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities
that might be necessary should the Company be unable to continue as a going concern.
Material
Commitments
We
have no material commitments as of May 31, 2025.
Recent
Accounting Pronouncements
In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which introduces more detailed
requirements for annual disclosures for income taxes. The ASU requires public business entities to present specific categories in the
income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09
also requires all entities to disclose the amounts of income taxes paid, net of refunds received, disaggregated by federal, state, and
foreign jurisdiction. The ASU is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the
effects, if any, that the adoption of ASU 2023-09 may have on its financial position, results of operations, cash flows, or disclosures.
In
November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures
(Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public business entities to disclose specific information
about certain costs and expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and
interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating
the effects, if any, that the adoption of ASU 2024-03 may have on its financial position, results of operations, cash flows, or disclosures.
There
are no other recently issued accounting pronouncements that have not yet been adopted that the Company considers material to its consolidated
financial statements.
29 | Page
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK.
As a “smaller reporting company” as
defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Our Management is responsible for establishing
and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-14(a)(e) and 15d-14(a) under the Exchange Act)
that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act
is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s Management,
including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions,
as appropriate to allow timely decisions regarding required disclosure.
An evaluation was conducted under the supervision
and with the participation of our Management of the effectiveness of the design and operation of our disclosure controls and procedures
as of May 31, 2025. Based on our Management’s evaluation under the framework in Internal Control-Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway Commission, our Management concluded that our disclosure controls
and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit
under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.
A material weakness is a control deficiency, or
combination of control deficiencies, such that there is a reasonable possibility that a material misstatement of the annual or interim
financial statements will not be prevented or detected on a timely basis. In connection with the assessment described above, Management
identified the following control deficiencies that represent material weaknesses as at May 31, 2025:
■
Due to our limited resources, we do not have enough accounting personnel with extensive experience in maintaining books and records and preparing financial statements in accordance with U.S. GAAP which could lead to untimely identification and resolution of accounting matters inherent in our financial transactions in accordance with U.S. GAAP.
■
The Company has insufficient written policies and procedures for accounting and financial reporting, which led to inadequate financial statement closing process.
■
The Company has a lack of segregation of duties, a lack of audit committee or independent governance/oversight.
Changes in Internal Controls over Financial
Reporting
There have been no changes in the Company’s
internal control over financial reporting during the three months period covered by this Quarterly Report that have materially affected,
or are reasonably likely to materially affect the Company’s internal control over financial reporting.
30 | Page
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are not currently subject to any legal proceedings,
and to the best of our knowledge, no such proceeding is threatened, the results of which would have a material impact on the Company’s
properties, results of operations, or financial condition. Nor, to the best of our knowledge, are any of the Company’s officers
or directors involved in any legal proceedings in which we are an adverse party.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS
The Management is not aware of any unregistered
sales of equity securities and use of proceeds.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
No senior securities were issued and outstanding
during the three-month period ended May 31, 2025
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable to our Company.
ITEM 5. OTHER INFORMATION
None.
31 | Page
ITEM 6. EXHIBITS
Exhibits:
10.1 Certificate of Amendment, filed with the Secretary of State of Nevada on September 9, 2024*
10.2 Share Transfer Agreement between Low Wai Koon and Unex Holdings Inc., dated December 20, 2021*
10.3 Share Transfer Agreement between Low Wai Koon and WKL Global Limited, dated December 20, 2021*
10.4 Share Transfer Agreement between Low Wai Koon and EvoAir International Limited, dated December 20, 2022*
10.5 Form of Share Exchange Agreement between certain sellers and WKL Eco Earth Holdings Pte. Ltd. whereby Unex Holdings Inc. is the Issuer, dated December 20, 2021*
10.6 Form of Share Exchange Agreement between certain sellers and WKL Eco Earth Holdings Pte. Ltd. whereby Unex Holdings Inc. is the Issuer, dated December 20, 2022*
10.7 Form of Investment Exchange Agreement between certain Seller and WKL Eco Earth Holdings Pte. Ltd. whereby Unex Holdings Inc. is the Issuer, dated December 20, 2021*
10.8 Form of Deed of Assignment between Low Wai Koon and WKL Eco Earth Holdings Pte Ltd, dated December 20, 2021*
10.9 Form of Deed of Assignment between Low Wai Koon and WKL Eco Earth Holdings Pte Ltd, dated December 20, 2021*
10.10 Form of Subscription Agreement between Ang Lee Kim Jane and Unex Holdings Inc., dated February 15, 2022*
10.11 Form of Subscription Agreement between Wong Hon Wai and Unex Holdings Inc., dated June 3, 2022*
10.12 Supplemental Agreement between Wong Hon Wai and Unex Holdings Inc., dated October 19, 2022*
10.13 Form of Subscription Agreement between Regulation S Investors and Unex Holdings Inc., dated October 25, 2022*
10.14 Form of Subscription Agreement between Regulation D Investors and Unex Holdings Inc., dated October 25, 2022*
10.15 Form of Subscription Agreement between Regulation S Investors and Unex Holdings Inc., dated July 13, 2023*
10.16 Form of Subscription Agreement between Regulation S Investors and Unex Holdings Inc., dated September 7, 2023*
10.17 Form of Subscription Agreement between Regulation S Investor and EvoAir Holdings Inc., dated November 21, 2023*
31.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
31.2 Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002
101. INS Inline XBRL Instance Document
101. SCH Inline XBRL Taxonomy Extension Schema Document
101. CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101. DEF Inline XBRL Taxonomy Extension Definition Document
101. LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101. PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Previously filed
32 | Page
SIGNATURES
In accordance with the requirements of the Exchange
Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
EvoAir Holdings Inc.
Dated: July 11, 2025
By:
/s/ Low Wai Koon
Low Wai Koon
Chairman and Chief Executive Officer
Dated: July 11, 2025
By:
/s/ Ong Bee Chen
Ong Bee Chen
Chief Financial Officer
33 | Page
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.